Since the blood perfusion makes a critical contribution to the transport of nanoparticles to tumor sites through the EPR [179], the use of drugs such as angiotensin II for blood flow enhancement in the target area could be a possible solution for the improvement of EPR. This evidence concerns the gene AGT and neoplasm.